Predictors of Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection in Hong Kong

被引:60
|
作者
Mak, So Shan [1 ]
Yeo, Winnie
Lee, Yik Mun [1 ]
Mo, Kwok Fai [2 ]
Tse, Ka Yin [2 ]
Tse, Sut Mun [1 ]
Ho, Fung Ping [1 ]
Kwan, Wing Hong [1 ]
机构
[1] Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Clin Oncol, Comprehens Canc Trials Unit, Shatin, Hong Kong, Peoples R China
关键词
breast cancer; case-control study; lymphedema; risk factor; treatment-related complication;
D O I
10.1097/NNR.0b013e31818c3de2
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background. The incidence rate of breast cancer is rising rapidly in Hong Kong. Lymphedema is a serious long-term complication of breast cancer surgery and radiation therapy. Objective: The objectives of this study were to evaluate risk factors associated with the development of lymphedema for patients with breast cancer who have had an axillary lymph node dissection and to explore potential factors associated with moderate to severe lymphedema. Methods: This was a matched case-control study of 202 women undergoing a unilateral axillary dissection for breast cancer, consisting of 101 cases with lymphedema and 101 controls who matched cases in terms of surgery date, axillary radiotherapy, and cancer stage. Arm circumferences were measured to determine presence and severity of lymphedema. Potential risk factors were collected by using clinical data and a questionnaire. A multiple logistic regression was used to obtain the adjusted odds ratios for potential risk factors for developing lymphedema. Exploratory analysis was also performed to identify factors associated with the development of moderate to severe lymphedema. Results: Adjusted odds ratios for the development of lymphedema were 3.80 (95% confidence interval [CI] 1.84-7.87) for previous inflammation-infection and 1.06 (95% CI = 1.02-1.10) for an increase of 1 year of age at axillary dissection. On exploratory analysis, adjusted odds ratios for moderate to severe degree of lymphedema were 4.53 (95% CI = 2.16-9.52) for previous inflammation-infection, 2.94 (95% CI = 1.44-6.03) for operation on dominant arm, 1.11 (95% CI 1.01-1.22) for an increase of I kg/m(2) in body mass index (BMI) at recruitment, and 1.05 (95% CI = 1.01-1.10) for an increase of 1 year of age at recruitment time. Discussion: Previous inflammation-infection and advanced age at axillary dissection are risk factors associated with the initiation of lymphedema. Previous inflammation-infection, operation on the side of the dominant hand, obesity, and aging are potential risk factors associated with the aggravation of lymphedema. Greater BMI is still a risk factor for lymphedema progression even in a lower BMI population.
引用
收藏
页码:418 / 427
页数:10
相关论文
共 50 条
  • [21] AXILLARY LYMPH NODE DISSECTION IN THE MANAGEMENT OF BREAST CANCER
    Ozbas, Serdar
    Kocak, Savas
    JOURNAL OF BREAST HEALTH, 2006, 2 (02): : 59 - 63
  • [22] Axillary lymph node dissection in ovary cancer patients with axillary lymph node metastasis
    So-Youn, Junf
    Cheol, Lim Myong
    Sang-Soo, Seo
    Sokbom, Kang
    Ho, Kim Sun
    Woo, Yoo Chong
    Kyongran, Koh
    Seeyoun, Lee
    Han-Sung, Kang
    Sook, Lee Eun
    Sang-Yoon, Park
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 36 - 36
  • [23] Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis
    Yoo, Tae-Kyung
    Kang, Bong Joo
    Kim, Sung Hun
    Song, Byung Joo
    Ahn, Juneyoung
    Park, Woo-Chan
    Chae, Byung Joo
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (02) : 403 - 409
  • [24] Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis
    Tae-Kyung Yoo
    Bong Joo Kang
    Sung Hun Kim
    Byung Joo Song
    Juneyoung Ahn
    Woo-Chan Park
    Byung Joo Chae
    Breast Cancer Research and Treatment, 2020, 181 : 403 - 409
  • [25] Histopathological predictors of axillary lymph node metastases in patients with breast cancer
    Mitsuyama S.
    Anan K.
    Toyoshima S.
    Nishihara K.
    Abe Y.
    Iwashita T.
    Ihara T.
    Nakahara S.
    Katsumoto F.
    Tamae K.
    Abe R.
    Hachitanda Y.
    Breast Cancer, 1999, 6 (3) : 237 - 241
  • [26] Predictors of axillary lymph node metastases in patients with impalpable breast cancer
    Perre, CI
    Koot, VCM
    vanderHeijden, EPA
    Vossen, V
    deJong, JR
    Ruitenberg, HM
    BREAST, 1997, 6 (03): : 143 - 145
  • [27] Axillary lymph node dissection in breast cancer patients after sentinel node biopsy
    Jessing, Christina
    Langhans, Linnea
    Jensen, Maj-Britt
    Talman, Maj-Lis
    Tvedskov, Tove Filtenborg
    Kroman, Niels
    ACTA ONCOLOGICA, 2018, 57 (01) : 166 - 169
  • [28] Lymphoscintigraphy in patients with breast cancer-related lymphedema after sentinel lymph node dissection and axillary radiation therapy
    Oh, Se Hyun
    Kim, Ju Hyeon
    Seong, Seung Tae
    Park, Jun Young
    Lee, Jae Hyun
    Kim, Ghi Chan
    Jeong, Ho Joong
    Sim, Young Joo
    MEDICINE, 2022, 101 (49) : E31985
  • [29] Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients
    Cady, B
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 77 (03) : 149 - 152
  • [30] Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients
    Noguchi, M
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 76 (02) : 144 - 156